Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03536897 · ClinicalTrials.gov registry record
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
A clinical trial of Breast Cancer, sponsored by Mount Carmel Health System.
- Recruiting
- Registry status
- 168
- Enrollment target
- 1
- Study location
NCT03536897: Recruiting study of Breast Cancer, sponsored by Mount Carmel Health System.
NCT03536897 is a study of Breast Cancer that is actively recruiting participants, run by Mount Carmel Health System. The registered enrollment target is 168 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03536897, a study of Breast Cancer, is actively recruiting participants, sponsored by Mount Carmel Health System.
- RECRUITING
- Registry status
- 168 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, registry trial which will enroll women aged 65 and above with early stage, low risk breast cancer who will be treated with partial mastectomy and intraoperative radiation therapy (IORT). The primary aim is to determine the 5-year risk of in-breast tumor recurrence. Secondary aims include identification of acute- and late-toxicity, cosmetic result, disease-free survival and overall survival.
Primary Outcome
Ipsilateral In-Breast Tumor Recurrence (IBTR): defined as biopsy-proved invasive or in situ breast cancer (except LCIS) in the ipsilateral breast.
Conditions Studied
Interventions
- RADIATION IORT
Study Locations (1)
Ohio
- Mount Carmel West Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2018-02-27 |
| Est. Completion | 2028-02-27 |
What NCT03536897 shows while recruiting
NCT03536897 is an observational study that tracks outcomes without assigning an intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which IORT is the first listed.
NCT03536897 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03536897 about?
NCT03536897 is a clinical study titled "IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry". This is a prospective, registry trial which will enroll women aged 65 and above with early stage, low risk breast cancer who will be treated with partial mastectomy and intraoperative radiation therapy (IORT). The primary aim is to determine the 5-year risk of in-breast tumor recurrence. Secondary a...
What is the current status of trial NCT03536897?
This trial is currently recruiting. The enrollment target is 168 participants. The study started on 2018-02-27. Estimated completion is 2028-02-27.
What conditions does trial NCT03536897 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT03536897?
The interventions under investigation include: IORT (RADIATION).
Who is sponsoring clinical trial NCT03536897?
This trial is sponsored by Mount Carmel Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03536897 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03536897's enrollment target sits among peer trials
168 424th of 1224 higher than 801 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
- NCT04169737 · 168 participants · Phase 2
Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI